Concepedia

Roman Kischel

RK

Statistics

Publications

25

Citations

2.3K

H-Index

20

Active since

2001

Affiliations

Amgen (Germany)(Current)

Amgen (United States)

Ludwig-Maximilians-Universität München

German Cancer Research Center

3D-Micromac (Germany)

Roman Kischel is an author at Amgen (Germany) specializing in immunology, cancer immunology, and cancer immunotherapy.

Publications per year

2001–2025

25

Publications

25

Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism

Christina Krupka, Peter Kufer, Roman Kischel et al. · Leukemia · 2015 · 249 citations

, , +16

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

Nora Philipp, Maryam Kazerani, Alyssa Nicholls et al. · Blood · 2022 · 245 citations · Full text

, , +17

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330

Christina Krupka, Peter Kufer, Roman Kischel et al. · Blood · 2013 · 207 citations

, , +17

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML

George S. Laszlo, Chelsea J. Gudgeon, Kimberly H. Harrington et al. · Blood · 2013 · 173 citations · Full text

, , +14

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Proceedings of the National Academy of Sciences · 2010 · 167 citations

, , +17

1–5 of 25